Fatty acid binding protein 4 (FABP4), cytokeratin 18 (CK-18), and fibroblast growth factor 21 (FGF21) have all emerged as potential circulating biomarkers for NAFLD. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.